Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
ConditionWrinkle
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-65
SponsorGlobal Aesthetics LLC
About this trial
A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.
Eligibility criteria
Qualifiers
Individuals of both genders.
Must be in good physical health.
Age between 20 and 65 years.
Presence of both static (unchanging) and moderate dynamic (movement-induced) wrinkles on the forehead or glabellar region.
Disqualifiers
Pregnant or breastfeeding female.
Age below 20 or above 65 years.
History of neuromuscular disorders, such as myasthenia gravis.
History of facial surgery or presence of scars in the treatment area that could potentially interfere with or confound the results of the study.
Trial design
Treatments tested in this trial
- Botulinum toxin type A
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov